{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:47:36Z","timestamp":1765554456386,"version":"3.48.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.7759\/cureus.99048","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:20:02Z","timestamp":1765552802000},"source":"Crossref","is-referenced-by-count":0,"title":["Chromogranin A-Associated Tubulopathy in a Patient With Neuroendocrine Tumor"],"prefix":"10.7759","author":[{"given":"Matthew","family":"Sanborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha","family":"Maity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Limmonick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aqeel","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2023-0044","article-title":"Diagnosis and management of neuroendocrine tumours","volume":"23","author":"Cuthbertson DJ","year":"2023","unstructured":"Cuthbertson DJ, Shankland R, Srirajaskanthan R. Diagnosis and management of neuroendocrine tumours. Clin Med (Lond). 2023, 23:119-24. 10.7861\/clinmed.2023-0044","journal-title":"Clin Med (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.3456","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"8","author":"Dasari A","year":"2025","unstructured":"Dasari A, Mehta K, Byers LA, et al.. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Netw Open. 2025, 8:e2034567. 10.1001\/jamanetworkopen.2025.3456","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v7.i1.9","article-title":"Chromogranin A as a valid marker in oncology: Clinical application or false hopes?","volume":"7","author":"Gkolfinopoulos S","year":"2017","unstructured":"Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes?. World J Methodol. 2017, 7:9-15. 10.5662\/wjm.v7.i1.9","journal-title":"World J Methodol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor","volume":"27","author":"Korse CM","year":"2009","unstructured":"Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. J Clin Oncol. 2009, 27:4293-9. 10.1200\/JCO.2008.18.7047","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Shah MH","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB, et al.. Neuroendocrine and adrenal tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:839-68. 10.6004\/jnccn.2021.0032","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.04.025","article-title":"Chromogranin A tubulopathy: Differing histopathologic patterns of acute tubular\u00a0injury in the setting of neuroendocrine neoplasms","volume":"4","author":"Sekulic M","year":"2019","unstructured":"Sekulic M, Waikar S, Motwani SS, Weins A, Rennke HG. Chromogranin A tubulopathy: Differing histopathologic patterns of acute tubular\u00a0injury in the setting of neuroendocrine neoplasms. Kidney Int Rep. 2019, 4:1085-93. 10.1016\/j.ekir.2019.04.025","journal-title":"Kidney Int Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393424-chromogranin-a-associated-tubulopathy-in-a-patient-with-neuroendocrine-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:20:02Z","timestamp":1765552802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393424-chromogranin-a-associated-tubulopathy-in-a-patient-with-neuroendocrine-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.99048","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}